Factors associated with prolonged duration of viral clearance in non-severe SARS-CoV-2 patients in Osaka, Japan

Abstract

Background We investigated factors associated with prolonged viral clearance of SARS-CoV-2 among non-severe adult patients in Osaka, Japan. A total of 706 laboratory-confirmed COVID-19 patients were enrolled in this longitudinal observational study between 29 January 2020 and 31 May 2020, across 62 hospitals and three non-hospital recuperation facilities. Methods Logistic regression analysis was performed to investigate the factors associated with prolonged (29 days: upper 25% in duration) viral clearance of SARS-CoV-2. Linear regression analysis was conducted to assess these factors 14 days after symptom onset. Results The median duration of viral clearance was 22 days from symptom onset. After adjustment for sex, age, symptoms, comorbidity, and location of recuperation, comorbidities were associated with prolonged duration: (OR, 1.77 [95% CI, 1.11–2.82]) for one, (OR, 2.47 [95% CI, 1.32–4.61]) for two or more comorbidities. Viral clearance 14 days after symptom onset was 3 days longer for one comorbidity and 4 days longer for two or more comorbidities compared to clearance when there was no comorbidity. Conclusion The presence of comorbidity was a robust factor associated with a longer duration of viral clearance, extending by 3 to 4 days compared to patients with no comorbidity.

Detectable Duration of Viable SARS-CoV-2, Total and Subgenomic SARS-CoV-2 RNA in Noncritically Ill COVID-19 Patients: a Prospective Cohort Study

“…In this cohort, analysis of factors associated with the duration of viral shedding showed that receipt of 2-dose vaccination was the protective factor for longer viral RNA shedding. Previously identified associated factors included older age, sex, presence of comorbidity, and the receipt of steroid ( 27 – 30 ). We could identify some of these factors in the univariate model.…”

Comorbidity Status of Deceased of Covid-19 Patients in Malaysia

“…Covid-19 patients with comorbid condition not only affect the prognosis, it also reduces the time taken for recovery. According to the study, viral clearance will take 3 days longer for one comorbidity and 4 days longer for two or more (Hoffman et al, 2021). This mainly affect the elderly compared to younger individual.…”

Contemporary Concise Review 2021: COVID‐19 and other respiratory infections

“…11 The duration of viral shedding may be prolonged in males, elderly, immunocompromised hosts, corticosteroid users and those with high fever, delayed hospitalization, severe or critical illnesses. 12,13 The factors that affect the clinical sensitivity or specificity of SARS-CoV-2 tests include days from symptom onset, sampling site and antigen test compared with reverse transcriptase-PCR testing. 14 A study with air and environmental samplings has shown that SARS-CoV-2 is evolving towards more efficient aerosol transmission, and loose-fitting masks provide only modest source control.…”

“…The duration of viral shedding may be prolonged in males, elderly, immunocompromised hosts, corticosteroid users and those with high fever, delayed hospitalization, severe or critical illnesses. 12 , 13 The factors that affect the clinical sensitivity or specificity of SARS‐CoV‐2 tests include days from symptom onset, sampling site and antigen test compared with reverse transcriptase‐PCR testing. 14 …”